4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000095
General Counsel sold 1,039 shares at $95.71 ($99,443)
From the SEC's structured data for this filing
Trades in this filing
Quinlan Paul T · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sale : show line 1 in the form | −1,039 | $95.71 | $99,443 | 29,995 | D |
| Open-market sales · 1,039 sh · avg $95.71 · $99,443 | ||||||
Loading xslF345X06/form4.xml…